首页> 外文期刊>Romanian Biotechnology Letters >IN VITRO activity of β-amirinic phytocompounds – a basic screening for breast cancer therapy
【24h】

IN VITRO activity of β-amirinic phytocompounds – a basic screening for breast cancer therapy

机译:β-氨基尿嘧啶植物化合物的体外活性–乳腺癌治疗的基本筛选

获取原文
获取外文期刊封面目录资料

摘要

As a result of biotechnological research concerning the indigene phytotherapeutic potential follow-up, we obtained two f-amirinic compounds (GSO-1 and GSO-2) with antitumorous indications. In order to define the specific target action of these compounds, we developed an “in vitro” experimental model for antiproliferative status evaluation on adherent, epithelial type breast adenocarcinoma (MCF-7 cell line). The biocompounds were tested at different concentrations, at 24 and 48h cell culture treatment, as a screening of most important parameters for antitumorous activity (cell proliferation, DNA synthesis, apoptosis). The target parameters were obtained by cellular analysis methods as microscopy and flow cytometry, using competitive software. The results marked a significant and differentiated activity of GSO-1 and GSO-2. The first one is a relevant apoptosis inducer, but the second compound acts as an inhibitor for MCF-7 cells proliferation and DNA synthesis.
机译:作为有关indigene植物治疗潜力后续研究的生物技术研究的结果,我们获得了两种具有抗肿瘤适应症的f-氨基ami胺类化合物(GSO-1和GSO-2)。为了定义这些化合物的特定靶作用,我们开发了一种“体外”实验模型,用于评估粘附的上皮型乳腺癌(MCF-7细胞系)的抗增殖状态。在24和48小时的细胞培养处理中,对不同浓度的生物化合物进行了测试,以筛选出最重要的抗肿瘤活性参数(细胞增殖,DNA合成,细胞凋亡)。使用竞争软件通过细胞分析方法(如显微镜和流式细胞仪)获得目标参数。结果表明,GSO-1和GSO-2具有明显的分化活性。第一个是相关的细胞凋亡诱导剂,但是第二个化合物充当MCF-7细胞增殖和DNA合成的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号